Elevated GMP Manufacturing
GMP Manufacturing of Pharma-Quality Psychoactive and Psychotropic Compounds
From Bulk to Market: Precisely Packaging Cannabis for Global Markets
HYTN specializes in the processing of cannabis products to meet the highest GMP standards. Our capabilities in this area include:
Final Packaged Goods - Jars
Final Packaged Goods - Bags
Bulk Packaging - Bags
Solventless Extract Manufacture - Jars
Cannabis Vape Manufacturing - 510 Cartridge
From Source to Solution: Crafting High-Quality APIs for Clinical Applications
HYTN excels in the fabrication of active pharmaceutical ingredients (APIs), ensuring they meet the highest standards of purity and efficacy. Our capabilities in this area include:
Live Resin API
Bulk Dry Flower API
Bulk Dry Psilocybin Mushroom API
Bulk Solventless Extraction API
From Nature to Nurture: Expertly Processing Psilocybin for Therapeutic Use
HYTN is among the global few GMP Certified sites to cultivate, process and release psilocybin mushrooms. Our capabilities in this area include:
Final Packaged Goods - 1 g Sachet
Bulk Packaging - Bags
From Plant to Product: Crafting Quality Cannabis Goods for Consumer Markets
HYTN specializes in creating high-quality consumer cannabis products, ensuring consistency, safety, and satisfaction. Our capabilities in this area include:
Nano Emulsions
Beverages
Edibles
Dry Flower Processing
Non Solid Extracts
Our Facility
GMP-Licenced, Right-Sized Facility for Innovative and Scalable Manufacturing
Our purpose built facility is designed to meet GMP standards balancing innovation, scalability, and cost-efficiency. Built "right-sized" it ensures lower operating expenses without compromising on quality or capacity and allows HYTN to operate sustainably and economically.
Our Facility
Capacities and Capabilities:
GMP Finished Cannabis Goods Packaging: 15 kg per shift
GMP Bulk Packaging of Dry Cannabis Flower: 75 kg per shift
GMP Finished Psilocybin Mushroom Goods Packaging: 5 kg per shift
Production Capacity for Active Ingredient Infused Beverages: 6,000 units per shift
Production Capacity for Active Ingredient Infused Edibles: 10,000 units per shift
Active Emulsion Capacity: 50 mg/ml with a bulk capacity of 400 L per shift
Licensed Storage Capacity: 230 sq. m. / 2100m3 (31 standard shipping containers)
Licences and Certifications
HYTN’s quality system meets the requirements of the European Pharmacopoeia (Ph. Eur.), German Pharmacopoeia (Deutsches Arzneibuch, DAB) ,Australia’s Therapeutic Goods Administration (TGA) TGO 93 and TGO 100, British Pharmacopoeia (BP) and includes the following:
GMP Drug Establishment Licence (Health Canada)
PIC/S GMP Medicine Manufacture Certificate - Bulk
PIC/S GMP Medicine Manufacture Certificate - Finished Product
EudraGMDP Database Registred (In Process)
Controlled Drugs and Substances Dealers License
Cannabis Research Licence
Cannabis Standard Cultivation Licence
Cannabis Standard Processing Licence
Cannabis Medical Sales Licence
Our Proprietary
Elevation Technology®
Elevating Product Experience with Clear, Odorless Emulsions, featuring:
Clear, Odorless Emulsions: Creates flawless emulsions for finished products.
Nano-Sized Droplets (<80 nm): Encapsulates high-quality lipophilic actives in stable nano-sized droplets, ensuring increased absorption and enhanced bioavailability.
Industry-Leading Stability: Combines nano emulsification technologies with custom machinery and proprietary processes for stable active emulsions.
Consistent Effects: Delivers rapid, predictable, and consistent effects.
Thermodynamically and Kinetically Stable: The nano-sized droplets are stable, enhancing the product's effectiveness.
Stackable and Predictable Formulations: Ensures a consistent experience with each use.
Elevation Technology® plays a crucial role in generating a Novel Chemical Entity (NCE) by creating unique and stable nano-emulsions that improve the bioavailability and efficacy of active ingredients. This proprietary technology allows for the precise formulation of cannabinoids and other compounds into new, patentable forms, effectively transforming them into NCEs.
By enhancing the solubility, stability, and absorption rates of these compounds, Elevation Technology® not only improves the therapeutic potential but also meets the rigorous standards required for pharmaceutical applications. This innovative approach positions HYTN at the forefront of cannabinoid-based pharmaceutical development, offering new opportunities for specialized formulations and targeted therapeutic applications.
Our Team
Leading with Vision, Expertise, and Innovation to Drive Success.
-
As the founder and president of the award-winning Electric Bicycle Brewing, Elliot has mastered the art of building forward-thinking brands in competitive markets. His strategic acumen and trend analysis skills have enabled him to distinguish his products in crowded segments. Recently, Elliot has leveraged his expertise to consult on and manage ten diverse product launches, ranging from niche craft brands to large-scale international co-pack manufacturing projects.
-
Jason holds an M.Sc. in Molecular Genetics and brings over 15 years of experience in the pharmaceutical industry. His career includes a tenure as head of the RX Division for a leading dermatology company. With expertise spanning medical devices, pharmaceuticals, fertility, and cannabis industries, Jason has built and led operational, regulatory, and quality systems. Prior to joining HYTN, he co-founded The Flowr Corporation (TSXV: FLWR), where he served as SVP - Operations and Chief Research and Innovation Officer.
Prior to joining HYTN Jason co- founded and served as SVP - Operations and Chief Research and Innovation Officer at The Flowr Corporation (TSXV: FLWR).
-
Coming soon.
-
An entrepreneur with unparalleled foresight and historic firsts in the cannabinoid industry. Established Brains as Brazil’s first registered medical cannabis product. Partnered with the largest vitamin distribution company in the UK. Co-founder of Sun Pharm, successfully RTO’ed Bevo to create Canadian LP; a founding member of the CMC and CDPRG.
